Abstract
Background and Aims : Monocyte chemoattractant protein-1 (MCP-1) is a proinflammatory chemokine, which plays a key role in the pathophysiology of both atherosclerosis and diabetes. MCP-1 is involved in the development of neoatherosclerosis after percutaneous coronary intervention (PCI). Investigate serum MCP-1 levels in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) depending on the previous history of PCI.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
